saroglitazar
Jump to navigation
Jump to search
English[edit]
Etymology[edit]
Probably from s(ulfanyl) + ar(yl) + -o- + -glitazar (“peroxisome proliferator activated receptors-α and -γ agonist”).
Pronunciation[edit]
- (General American) IPA(key): /ˌsæɹ.əˈɡlɪt.əˌzɑɹ/
Noun[edit]
saroglitazar (uncountable)
- (pharmacology) A particular glitazar for the treatment of type 2 diabetes mellitus and dyslipidemia.